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Whether the hexosamine biosynthesis pathway acts
as a nutrient-sensing pathway is still unclear. Glucose
is directed into this pathway by GFAT. Because the
activity of GFAT is tightly regulated, we examined
whether UDP-hexosamine levels can increase signifi-
cantly and dose-dependently in response to elevated
glucose concentrations. In glucosamine-treated 3T3-
L1 adipocytes, inhibition of insulin-stimulated glucose
uptake was highly correlated with UDP-hexosamine
levels (r = 0.992; p < 0.0001 for UDP-GlcNAc and
r = 0.996; p < 0.0001 for UDP-GalNAc). Incubation
of 3T3-L1 adipocytes with 0.1 µM insulin for 24 h in
medium containing 1 and 5 mM glucose increased the
rate of glucose uptake by 365% and 175% compared
to untreated cells, respectively. This increase was not
observed when the cells were incubated for 24 h with
insulin in medium containing 10 or 25 mM glucose.
However, treatment of cells with insulin and 1, 5, 10,
or 25 mM glucose resulted in similar increases in lev-
els of UDP-GlcNAc and UDP-GalNAc that always
amounted to approx 30–40% above baseline values.
This led us to conclude that despite exposure of adipo-
cytes to conditions of extreme and prolonged glucose
disposal, the increases in cellular UDP-hexosamines
were minimal and not dependent on the extracellular
glucose concentration. Taken together, our results are
in line with the hypothesis that in glucosamine-treated
adipocytes UDP-hexosamines influence insulin-stimu-
lated glucose uptake. However, our observations in
glucose-treated adipocytes argue against the possibil-
ity that UDP-hexosamines function as a nutrient-sen-
sor, and question the role of the hexosamine biosynthe-
sis pathway in the pathogenesis of insulin resistance.
Key Words: 3T3-L1 adipocytes; hexosamine biosynthe-
sis pathway; UDP-N-acetyl glucosamine; UDP-N-ace-
tyl galactosamine; glucose uptake.
Introduction
Glucosamine treatment, which increases the intracellular
levels of metabolites of the hexosamine biosynthesis path-
way, effectively attenuates insulin-stimulated glucose up-
take in many different insulin-sensitive models (1–6). This
has led to the hypothesis that this pathway functions as a
nutrient-sensing pathway and may be involved in the patho-
genesis of type 2 diabetes mellitus. The idea is that an over-
supply of cells with glucose would lead to accumulation of
UDP-hexosamines, which in turn would down-regulate insu-
lin-stimulated glucose uptake (reviewed in refs. 7 and 8).
The hexosamine biosynthesis pathway starts with the
conversion of fructose-6-phosphate into glucosamine-6-phos-
phate through the action of the enzyme glutamine:fructose-
6-phosphate amidotransferase (GFAT) (9). The end-products
of this pathway are uridinediphosphate-N-acetylglucosamine
(UDP-GlcNAc) and UDP-N-acetylgalactosamine (UDP-
GalNAc). In contrast to glucosamine, which bypasses GFAT,
glucose enters the hexosamine biosynthesis pathway through
the action of the rate-limiting enzyme GFAT and it is there-
fore questionable whether high glucose levels result in sim-
ilarly increased UDP-hexosamine levels as observed with
glucosamine treatment.
Nevertheless, a number of studies demonstrated that
glucose can induce insulin resistance via the hexosamine
biosynthesis pathway. In transgenic mice overexpressing
GFAT, an increased flux of glucose is directed through the
hexosamine biosynthesis pathway. These transgenic mice
develop insulin resistance, reflected by a decreased glu-
cose disposal rate during a hyperinsulinemic-euglycemic
clamp (10) and reflected by a significantly lower uptake of
2-deoxyglucose in hindlimb muscle, measured during
hyperinsulinemia (11).
However, the transgenic mouse model does not provide
evidence that, under circumstances in which GFAT activity
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is not artificially increased, glucose can induce insulin re-
sistance via the hexosamine biosynthesis pathway as the
activity of GFAT is allosterically inhibited through feed-
back by the downstream product UDP-GlcNAc (reviewed
in ref. 12). In line with the presence of such feedback inhi-
bition, Nelson et al. (13) observed that an increased glucose
flux into 3T3-L1 adipocytes clearly attenuated insulin-
stimulated glucose uptake but increased the intracellular
amounts of UDP-hexosamines by only 30%. These authors
also showed that treatment of 3T3-L1 adipocytes with glu-
cosamine lowered insulin-stimulated glucose uptake only
when the amounts of UDP-hexosamines in the adipocytes
increased by more than 400%. These results suggest that an
increased glucose flux into 3T3-L1 adipocytes does not
induce insulin resistance via the hexosamine biosynthesis
pathway.
Because the activity of GFAT is tightly regulated (12), we
questioned whether major increases in the cellular amounts
of UDP-hexosamines can occur in response to elevated glu-
cose concentrations. To this end, we treated 3T3-L1 adipo-
cytes for a prolonged time (24 h) with a very high insulin
concentration (0.1 µM) in medium containing various glu-
cose concentrations. As such, we exposed the adipocytes
to conditions of extreme and prolonged glucose disposal.
If the UDP-hexosamines function as a nutrient sensor, the
increase in cellular UDP-hexosamines should be depen-
dent on the glucose concentration.
Results
The Rate of Glucose Uptake and the Amounts of UDP-
Sugars in Glucosamine-Treated 3T3-L1 Adipocytes
First, we measured the insulin-stimulated rate of glu-
cose uptake in glucosamine-treated cells. Figure 1 shows
that in 3T3-L1 adipocytes not treated with glucosamine,
the unstimulated rate of glucose uptake was 1.07 ± 0.29
nmol 2-DOG/10 min/well. Addition of 0.1 µM insulin for
10 min increased the rate of glucose uptake to 3.86 ± 0.21
nmol 2-DOG/10 min/well. Hence, insulin stimulated the
rate of glucose uptake by 2.79 ± 0.08 nmol 2-DOG/10 min/
well. Glucosamine inhibited the insulin-stimulated glucose
uptake in a dose-dependent manner. In comparison with
untreated cells, treatment with 2.5, 10, and 50 mM glucos-
amine significantly lowered insulin-stimulated glucose
uptake to 2.07 ± 0.26 (26% reduction, p = 0.033), 1.34 ± 0.21
(52% reduction, p = 0.02), and 0.81 ± 0.08 (71% reduction,
p < 0.0005) nmol 2-DOG/10 min/well, respectively.
Next, we investigated the amounts of nucleotide-linked
sugars in 3T3-L1 adipocytes under these conditions. Figure
2 shows that 3T3-L1 adipocytes not treated with glucos-
amine contained 0.76 ± 0.01 nmol UDP-GlcNAc/well, 0.31
± 0.01 nmol UDP-GalNAc/well, and 0.41 ± 0.02 nmol UDP-
glucose/well. Treatment with glucosamine dose-dependently
increased the amounts of the two UDP-hexosamines and
decreased the amount of UDP-glucose. In comparison with
untreated cells, the amount of UDP-GlcNAc (p = 0.006) and
the amount of UDP-GalNAc (p = 0.044) were already sig-
nificantly increased following 1 h of 0.25 mM glucosamine
treatment. When cells were treated with 2.5 mM glucos-
amine for 1 h, which significantly lowered insulin-stim-
ulated glucose uptake, the amounts of UDP-GlcNAc and
UDP-GalNAc were increased by 56 ± 3% and 54 ± 5%,
respectively. The amount of UDP-glucose was 0.14 ± 0.01
nmol/well after 1 h of 50 mM glucosamine, which was sig-
nificantly decreased (p = 0.014) compared to the amount in
untreated cells. Figure 3 shows that there is a strong nega-
tive correlation (r = 0.992; p < 0.0001 for UDP-GlcNAc
and r = 0.996; p < 0.0001 for UDP-GalNAc) between the
rate of insulin-stimulated glucose uptake and the amounts
of UDP-GlcNAc and UDP-GalNAc at the different glu-
cosamine concentrations.
The Rate of Glucose Uptake and the Amounts of UDP-
Sugars in 24 h Insulin-Treated 3T3-L1 Adipocytes
The rate of glucose transport of insulin-treated 3T3-L1
adipocytes incubated at different glucose concentrations
was determined. Figure 4 shows that incubations of 3T3-
L1 adipocytes in medium containing 1, 5, 10, and 25 mM
glucose for 24 h did not affect basal or insulin-stimulated
glucose uptake. The average increase in the rate of glucose
uptake by 10 min of insulin at these four glucose concentra-
tions was 3.60 ± 0.10 nmol 2-DOG/10 min/well (increase
of 543%). In comparison with cells not exposed to insulin,
treatment with 0.1 µM insulin for 24 h significantly increased
Fig. 1. Effect of glucosamine treatment on insulin-stimulated glu-
cose uptake in 3T3-L1 adipocytes. Fully differentiated 3T3-L1
adipocytes were incubated for 1 h in reaction buffer containing 0,
0.25, 1, 2.5, 10, or 50 mM glucosamine in the absence of insulin
and glucose. Subsequently, cells were washed twice and incu-
bated without (circles) or with (squares) 0.1 µM insulin. After 10
min the rate of glucose uptake was determined. The values pre-
sented are the mean + SEM of four experiments. *Significantly
different from the increase in the rate of glucose uptake by insulin
in cells incubated in the absence of glucosamine.
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Fig. 2. Effect of incubation with glucosamine on the amounts of
UDP-hexosamines and UDP-glucose in 3T3-L1 adipocytes. Fully
differentiated 3T3-L1 adipocytes were incubated for 1 h in medium
containing 0, 0.25, 1, 2.5, 10, or 50 mM glucosamine in the absence
of insulin and glucose. Subsequently, cells were washed twice
and harvested, and the amounts of UDP-GlcNAc (upper graph),
UDP-GalNAc (middle graph) and UDP-glucose (lower graph)
in the cells were determined. The values presented are the mean
+ SEM of four experiments. *Significantly different from the
amounts of UDP-sugars in the cells incubated in the absence of
glucosamine.
Fig. 3. Relation between the amounts of UDP-GlcNAc and UDP-
GalNAc and the rate of insulin-stimulated glucose uptake. The
amounts of UDP-GlcNAc (closed circles) and UDP-GalNAc
(open circles) in glucosamine-treated 3T3-L1 adipocytes were
plotted against the rate of insulin-stimulated glucose uptake,
which was corrected for the rate of basal glucose uptake. With
increasing cellular amounts of UDP-GlcNAc and UDP-GalNAc,
the rate of insulin-stimulated glucose uptake declines.
Fig. 4. Effect of 24 h insulin treatment on glucose uptake in 3T3-
L1 adipocytes exposed to different glucose concentrations. The
3T3-L1 adipocytes were incubated in medium containing 1, 5, 10,
and 25 mM glucose in the absence of 0.1 µM insulin for 24 h (open
symbols). Subsequently, cells were washed and incubated in reac-
tion buffer in the absence of glucose and insulin. After 1 h the
reaction buffer was added without (circles) or with (squares) 0.1
µM insulin. After 10 min the rate of glucose uptake was deter-
mined. In addition, 3T3-L1 adipocytes were incubated in medium
containing 1, 5, 10, and 25 mM glucose in the presence of 0.1 µM
insulin (closed circles) for 24 h. Subsequently, cells were washed
and incubated in reaction buffer in the absence of glucose and
insulin. After 1 h the reaction buffer was refreshed and after 10
min the rate of glucose uptake was determined. The values pre-
sented are the mean + SEM of four or five experiments. *Signifi-
cantly different from corresponding cells treated for 24 h without
insulin.
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the rate of glucose uptake by 365 ± 49% (p = 0.008) and 175
± 16% (p = 0.012) when the cells were incubated in medium
containing 1 and 5 mM glucose, respectively. The rate of
glucose uptake was not significantly increased when the
24 h insulin treatment occurred with medium containing 10
or 25 mM glucose.
Next, we incubated cells for 24 h in medium with vary-
ing glucose concentrations in the absence or presence of
0.1 µM insulin after which the amounts of nucleotide-linked
sugars were assessed. The amounts of UDP-GlcNAc and
UDP-GalNAc in untreated as well as in insulin-treated
3T3-L1 adipocytes tended to increase upon incubation in
medium with increasing glucose concentrations for 24 h
(Fig. 5). However, it did not reach statistical significance.
In comparison with cells treated with 0.5 mM glucose, the
amount of UDP-glucose was significantly higher in 3T3-
L1 adipocytes following 24 h incubation in medium with
5 and 10 mM glucose. The latter was the case for both un-
treated as well as insulin-treated adipocytes.
Compared to untreated cells, the increase in the amounts
of UDP-GlcNAc, UDP-GalNAc, and UDP-glucose follow-
ing 24 h treatment with insulin at all glucose concentra-
tions was 36.8 ± 7.3% (ranging from 12 to 49%; p = 0.019),
38.0 ± 8.0% (ranging from 0 to 54%; p = 0.025), and 46.0
± 8.0% (ranging from 20 to 71%; p = 0.013), respectively.
Of note, the increases of the UDP-sugars were not affected
by the 1 h incubation in insulin- and glucose-free medium
(data not shown).
Prolonged Insulin Treatment
Stimulates the Production of UDP-GlcNAc
in Glucosamine-Treated 3T3-L1 Adipocytes
Because we found only a marginal increase in the amount
of UDP-GlcNAc during a prolonged period of excessive
glucose uptake, we examined whether prolonged insulin
treatment affects the activity of the hexosamine biosynthe-
sis pathway distal from GFAT. Therefore, 3T3-L1 adipo-
cytes were treated for 24 h with 25 mM glucose in the
absence or presence of 0.1 µM insulin and subsequently
treated for 1 h without or with 50 mM glucosamine after
which the amount of UDP-GlcNAc was determined. Figure
6 shows that 24 h treatment of 3T3-L1 adipocytes with insu-
lin significantly increased the amount of UDP-GlcNAc by
70 ± 19% (p = 0.02) compared to untreated cells. Treat-
ment of cells with 50 mM glucosamine for 1 h significantly
increased the amount of UDP-GlcNAc by 218 ± 24% (p =
0.002) compared to untreated cells. However, when glu-
cosamine was added to cells which were first treated with
insulin for 24 h, the amount of UDP-GlcNAc significantly
increased by 530 ± 43% (p = 0.008).
Discussion
We investigated the possibility that the hexosamine bio-
synthesis pathway operates as a nutrient-sensing pathway
in 3T3-L1 adipocytes by investigating whether UDP-hexos-
Fig. 5. Effect of 24 h insulin treatment on the amounts of UDP-
hexosamines and UDP-glucose in 3T3-L1 adipocytes exposed to
different glucose concentrations. Fully differentiated adipocytes
were incubated in medium containing 0.5, 1, 5, 10, and 25 mM
glucose in the absence (open symbols) or presence (closed sym-
bols) of 0.1 µM insulin for 24 h. Subsequently, cells were washed
twice and incubated in reaction buffer in the absence of glucose
and insulin. After 1 h cells were harvested and the amounts of
UDP-GlcNAc (upper graph), UDP-GalNAc (middle graph), and
UDP-glucose (lower graph) were determined. The values pre-
sented are the mean ± SEM of four or five experiments. *Signifi-
cantly different from the amount of UDP-glucose in cells incu-
bated in 0.5 mM glucose. #Significantly different from the amount
of UDP-sugars in cells treated without insulin for 24 h.
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amine levels reflect the amounts of glucose to which the
adipocytes are exposed. From our results it appears that
during conditions of extreme glucose disposal the cellular
amounts of UDP-hexosamines remain relatively constant.
In complete contrast, in glucosamine-treated 3T3-L1 adipo-
cytes the amounts of UDP-hexosamines increase in a dose-
dependent manner and correlate almost perfectly with the
decrease in insulin-stimulated glucose uptake. Taken together,
our results are in line with the hypothesis that in glucos-
amine-treated adipocytes cellular UDP-hexosamine levels
influence insulin-stimulated glucose uptake. However, our
observations in glucose-treated adipocytes argue against the
possibility that UDP-hexosamine levels function as a nutri-
ent sensor, and question the role of the hexosamine biosyn-
thesis pathway in the pathogenesis of insulin resistance.
Treatment of 3T3-L1 adipocytes with glucosamine for
1 h resulted in a rapid decrease in insulin-stimulated glu-
cose uptake. Incubation with 50 mM glucosamine almost
completely prevented an insulin-stimulated increase in the
rate of glucose transport. These observations are in agree-
ment with those of Heart et al. (15), who reported that glu-
cosamine dose-dependently decreases insulin-stimulated
glucose uptake in 3T3-L1 adipocytes and that 50 mM glu-
cosamine was required to maximally inhibit insulin-stimu-
lated glucose transport. Of note, we (16) and others (17) did
not identify a decrease in insulin sensitivity in humans dur-
ing short-term glucosamine infusion, which questions whether
in humans UDP-hexosamines can down-regulate insulin
signaling. We quantified the amounts of UDP-GlcNAc and
UDP-GalNAc in the murine adipocytes treated with glucos-
amine and observed a strong negative correlation between
the rate of insulin-stimulated glucose uptake, on one hand,
and the amounts of UDP-GlcNAc and UDP-GalNAc, on
the other hand. This is in line with the hypothesis that in
glucosamine-treated 3T3-L1 adipocytes increases in the
amounts of UDP-hexosamines cause a decrease in insulin-
stimulated glucose uptake. However, it has been demon-
strated that treatment of 3T3-L1 adipocytes with glucos-
amine decreases intracellular ATP levels (18). Moreover,
the decreases in ATP levels and inhibition of insulin-stimu-
lated glucose transport were highly correlated. Interestingly,
glucosamine-induced insulin resistance was prevented upon
addition of inosine, a compound that stimulates ATP pro-
duction. Based on these observations, it is suggested that
glucosamine inhibits insulin-stimulated glucose transport
by decreasing cellular ATP levels and not through elevated
UDP-hexosamine levels. Of note, the production of UDP-
hexosamines in the presence or absence of inosine was not
determined. Therefore, it cannot be excluded that, in the
presence of inosine, UDP-hexosamines are less effectively
produced in glucosamine-treated 3T3-L1 adipocytes. In con-
trast to the observations of Hresko et al. (18), others reported
that severe cellular ATP depletion in 3T3-L1 adipocytes
did not affect insulin-stimulated glucose uptake (19). The
latter study recognize their opposite findings compared to
Hresko et al. (18), and suggests that this might be due to
small but significant differences in the experimental condi-
tions. Nevertheless, it remains questionable whether glucos-
amine inhibits insulin-stimulated glucose uptake in 3T3-L1
adipocytes by decreasing the ATP levels.
The amount of UDP-glucose in 3T3-L1 adipocytes de-
creased in a dose-dependent manner when the cells were
treated with glucosamine. This might indicate that activa-
tion of the hexosamine biosynthesis pathway by incubation
of the cells with glucosamine either stimulates processing
of UDP-glucose to generate glycogen (20) or that the UDP
from UDP-glucose is released for the synthesis of UDP-
hexosamines (21).
Nelson et al. (13) reported that overnight treatment of
3T3-L1 adipocytes with 2.5 mM glucosamine increased the
amounts of UDP-hexosamines by 400% but did not affect
insulin-stimulated glucose uptake. However, when insulin
was present during treatment with 2.5 mM glucosamine,
the increase in UDP-hexosamines amounted to 900% and
insulin-stimulated glucose uptake was reduced in compar-
ison with cells not exposed to insulin. Therefore, these
authors concluded that to inhibit insulin-stimulated glu-
cose uptake in 3T3-L1 adipocytes the increase in cellular
UDP-hexosamine content should be more than 400%. In
contrast, we observed that incubation with only glucos-
amine (2.5 mM and higher doses) for 1 h already inhibited
insulin-stimulated glucose uptake. Moreover, insulin-stim-
Fig. 6. Effect of 24 h insulin followed by 1 h glucosamine treat-
ment on the amount of UDP-GlcNAc. Fully differentiated 3T3-
L1 adipocytes, incubated in medium containing 25 mM glucose,
were washed twice and incubated without (first bar) or with (third
bar) 50 mM glucosamine for 1 h in glucose- and insulin-free
medium. In addition, cells were treated with 0.1 µM insulin for 24
h, washed with PBS, and treated without (second bar) or with
(fourth bar) glucosamine (1 h, 50 mM). Next, cells were harvested
and the amount of UDP-GlcNAc was determined. The values
presented are the mean + SEM of four experiments. *Signifi-
cantly different from untreated cells.
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ulated glucose uptake was already significantly reduced
when the amounts of UDP-GlcNAc and UDP-GalNAc were
increased by 50%. When we treated 3T3-L1 adipocytes for
1 h with 50 mM glucosamine, which almost completely
inhibited insulin-stimulated glucose uptake, the amount of
UDP-GlcNAc increased by 218%. However, the amount
of UDP-GlcNAc increased further to 530% in cells treated
with 50 mM glucosamine for 1 h when these cells were first
exposed for 24 h to 0.1 µM insulin and 25 mM glucose. This
might explain why Nelson et al. (13), who treated the 3T3-
L1 adipocytes simultaneously with glucose, glucosamine,
and insulin, observed such large increases in UPD-hexos-
amine levels.
We found that the rate of glucose uptake was signifi-
cantly increased in 3T3-L1 adipocytes treated with 0.1 µM
insulin for 24 h when the cells were incubated in medium
with 1 and 5 mM glucose compared to cells not treated with
insulin. When the glucose concentration was increased to 10
and 25 mM, prolonged insulin treatment did not increase
the rate of glucose uptake. Others (14,22) also demon-
strated that prolonged exposure of 3T3-L1 adipocytes to
insulin (0.01–0.1 µM) increases the rate of glucose trans-
port at low concentrations of glucose. Moreover, it was dem-
onstrated that this increase in the rate of glucose transport
was accompanied with elevated cellular levels of GLUT-1
and not GLUT-4. In addition, it was shown that the amount
of GLUT-1, and not GLUT-4, at the plasma membrane was
increased of these long-term (hours) insulin-treated cells,
which is in contrast to short-term (minutes) insulin-treated
cells where predominantly the amount of GLUT-4 increases
at the plasma membrane. Hence, the stimulatory effect of
long-term insulin treatment on the amount of GLUT-1 at
the plasma membrane most probably explains the increase
in the rate of glucose uptake of our 24 h insulin-treated
3T3-L1 adipocytes in the presence of 1 and 5 mM glucose.
The observation that the rate of glucose uptake following
treatment with insulin for 24 h is dependent on the glucose
concentration, demonstrates that the amount of glucose that
has been taken up by the adipocytes is different between
cells incubated in low (1 and 5 mM) and cells incubated in
high (10 and 25 mM) glucose concentrations.
In earlier studies investigating glucose-induced insulin
resistance in 3T3-L1 adipocytes (13,14,23,24), the amount
of insulin that was added for a prolonged period of time was
relatively low (0.1–5 nM) compared to the concentration in
our experimental setting (0.1 µM). We recognize that the
high concentration of insulin for 24 h is unsuitable to study
the mechanism of glucose-induced insulin resistance, but
this concentration ensures a prolonged and profound in-
creased uptake of glucose during the 24 h treatment. In con-
trast to glucosamine treatment, 24 h treatment of 3T3-L1
adipocytes with insulin (0.1 µM) and glucose only margin-
ally increased the amounts of UDP-GlcNAc and UDP-
GalNAc by approx 30–40%. The fact that addition of 50 mM
glucosamine for 1 h to the 24 h insulin-exposed cells pro-
foundly increased the amounts of UDP-hexosamines rules
out the possibility that the 24 h insulin-treatment down-
regulates the activity of the hexosamine biosynthesis path-
way. Although we do not provide direct evidence for this,
the difference in the increases of the amounts of UDP-
hexosamines between glucosamine and glucose treatment
is most likely due to the fact that GFAT activity is inhibited
by UDP-GlcNAc. Moreover, it appears that the GFAT activ-
ity is controlled to such an extent that incubation of cells
with a high concentration of insulin and a high concentra-
tion of glucose did not yield more UDP-hexosamines com-
pared to cells incubated with the same high concentration
of insulin but with a low concentration of glucose.
In glucose-induced insulin-resistant 3T3-L1 adipocytes,
the cellular amounts of UDP-hexosamines increased by 30%
(13). In our glucosamine-treated adipocytes, an increment
of 50% in the amounts of UDP-GlcNAc and UDP-GalNAc
coincided with a significantly lowered insulin-stimulated
glucose uptake, suggesting that small increases in UDP-hex-
osamine levels already affect insulin signaling. Therefore,
it cannot be totally excluded that the hexosamine biosynthe-
sis pathway contributes to some degree in glucose-induced
insulin resistance.
To conclude, our data show that glucosamine-induced
insulin resistance in 3T3-L1 adipocytes is highly related
with intracellular UDP-hexosamine levels. Prolonged insu-
lin-mediated glucose loading in the adipocytes however,
increases the amounts of UDP-GlcNAc and UDP-GalNAc
only marginally and to a similar extent at all glucose con-
centrations. Taken together, our results are in line with the
hypothesis that in glucosamine-treated adipocytes cellular
UDP-hexosamine levels influence insulin-stimulated glu-
cose uptake. However, our observations in glucose-treated
adipocytes argue against the possibility that UDP-hexos-
amines act as a nutrient sensor, and question the role of the
hexosamine biosynthesis pathway in the pathogenesis of
insulin resistance.
Materials and Methods
Materials
Dulbecco’s modified Eagle’s medium (DMEM) was from
ICN Biomedicals (Irvine, CA, USA) and glucose-free
DMEM was from Life Technologies (Breda, The Nether-
lands). Fetal calf serum (FCS) was from PAA laboratories
(Linz, Austria). Glucosamine, 2-deoxyglucose (2-DOG),
3-isobutyl-1-methylxanthine (IBMX), and dexamethasone
were obtained from Sigma (St. Louis, MO, USA). Human
recombinant insulin was obtained from Eli Lilly (Nieuwe-
gein, The Netherlands) and [1-3H]-2-DOG (spec. act. 481
GBq/mmol) was purchased from Amersham Pharmacia
Biotech (Buckinghamshire, UK). All other chemicals were
of analytical grade.
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Adipogenesis of 3T3-L1 Cells
The 3T3-L1 cells (ATCC, Manassas, VA, USA) were
seeded in 12-well plates and grown to confluence in DMEM
with 25 mM glucose, 2 mM glutamine, and 10% (v/v) FCS
for 10 d. Subsequently, insulin (1.7 µM), IBMX (1 µM),
and dexamethasone (25 pM) were added. After 48 h, IBMX
and dexamethasone were omitted from the culture medium
and, after an additional 6 d of culture, insulin was also
omitted. After another 7 d of culture, the 3T3-L1 cells were
fully differentiated into adipocytes (more than 90% of the
cells contained lipid droplets) and used for analysis. The
amount of protein in the 12-wells was 328 ± 22 µg/well
(mean ± SD).
Treatment of 3T3-L1
Adipocytes with Glucosamine or Glucose
In case of glucosamine treatment, 3T3-L1 adipocytes
were incubated in DMEM with 25 mM glucose, 2 mM
glutamine but without FCS for 3 h. Subsequently, cells
were washed twice with phosphate buffered saline (PBS)
and incubated at 37°C for 1 h in reaction buffer containing
138 mM NaCl, 1.85 mM CaCl2, 1.3 mM MgSO4, 4.8 mM
KCl, 0.2% (w/v) BSA, and 50 mM N-[2-hydroxyethyl]piper-
azine-N'-[2-ethanesulfonic acid] (HEPES) adjusted to pH
7.4. In addition, cells were incubated for 1 h in reaction
buffer containing 0.25, 1, 2.5, 10, or 50 mM glucosamine.
In case of glucose and insulin treatment, cells were kept
in DMEM with 25 mM glucose, 2 mM glutamine, and 10%
(v/v) FCS and 0.5, 1, 5, 10, or 25 mM glucose in the absence
or presence of 0.1 µM insulin for 24 h. The FCS was omit-
ted during the last 3 h of incubation. Next, cells were washed
twice with PBS and incubated at 37°C for 1 h in reaction
buffer in the absence of glucose and insulin, to re-create
unstimulated cells as described by Thomson et al. (14).
After glucosamine or glucose and insulin treatment, cells
were washed with reaction buffer and, subsequently, the
rate of glucose uptake or the levels of the different UDP-
sugars were measured in these cells.
Glucose Uptake
To assess the rate of glucose uptake, cells were refreshed
with 500 µL reaction buffer without or with insulin (0.1
µM) and after 10 min, reaction buffer (250 µL) containing
27.8 kBq [1-3H]-2-DOG, and 1.5 mM 2-DOG without or
with 0.1 µM insulin was added. After 10 min of incubation
at 37°C, glucose uptake was terminated upon washing three
times with ice-cold PBS containing 10 mM glucose. Subse-
quently, cells were lysed in 1% (w/v) sodium dodecyl sul-
fate and 0.2 M NaOH. Internalized radioactivity was mea-
sured by liquid scintillation spectrometry.
Analysis of UDP-Hexosamines and UDP-Glucose
Analyses were performed as described previously (25).
In brief, adipocytes were washed twice with PBS, scraped
off the plate, and subsequently collected in 500 µL extrac-
tion buffer containing 100 mM KCl, 1 mM EDTA, and 50
mM KH2PO4, adjusted with KOH to pH 7.5. The homoge-
nate was sonicated (Branson Ultrasonics Corporation,
Model 250 sonifier, Danbury CT, USA) at 4°C by 10 bursts
of 5 s (output 1) using a microtip. The mixture was centri-
fuged at 60,000g for 15 min at 4°C. The supernatant (400
µL) was deproteinized by adding 1 volume of 1.2 M per-
chloric acid. After 5 min on ice, the mixture was centri-
fuged for 10 min at 15,000g and 4°C. The supernatant was
diluted with 10 volumes of 10 mM KH2PO4, adjusted with
H3PO4 to pH 2.5 and applied to LC-SAX ion-exchange
columns (Amersham, Buckinghamshire, UK). After wash-
ing, the samples were eluted with 1.5 mL KH2PO4 (150
mM), adjusted with KOH to pH 7.5. Finally, samples (150
µL) were injected on two LC-18T columns in series (25 cm
 4.6 mm, 5 µM; Supelco, Zwijndrecht, The Netherlands)
and separated by high-performance liquid chromatogra-
phy. Detection of UDP-glucose, UDP-N-acetylglucosamine,
and UDP-N-acetylgalactosamine was performed by UV at
262 nm.
Analysis of the Data
The conditions belonging to an experiment were applied
on one 12-well plate. An experiment was replicated four or
five times. Effects of the various experimental conditions
were tested by means of either one-way or two-way repeated
measures ANOVA and within subject factor contrasts were
tested for statistical significance (p < 0.05). Where appro-
priate, Spearman correlation coefficients (r) were deter-
mined or statistical analyses were performed with parallel
pair-wise t-test with correction according to Bonferroni.
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